mevalonic acid has been researched along with Kidney Failure, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benchitrit, J; Drüeke, TB; Edelman, A; Galmiche, A; Guerrera, IC; Guillonneau, F; Ivanovski, O; Joki, N; Lacour, B; Lucas, A; Maizel, J; Marçon, F; Massy, ZA; Nguyen-Khoa, T; Nikolov, IG; Phan, O | 1 |
| Fried, LF | 1 |
| Gagnon, RF; Pappu, AS; Stewart-Phillips, JL; Subang, MC; Subang, R | 1 |
| Guijarro, C; Keane, WF | 1 |
| De Paolis, P; Di Giulio, S; Lala, A; Menzinger, G; Scoppola, A | 1 |
| Boguslawski, W; Chmielewski, M; Nieweglowski, T; Rutkowski, B; Swierczynski, J | 1 |
2 review(s) available for mevalonic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kidney Failure, Chronic; Mevalonic Acid; Models, Biological; Proteinuria | 2008 |
Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
Topics: Animals; Anticholesteremic Agents; Cell Division; Collagen; Colony-Stimulating Factors; Extracellular Matrix Proteins; Gene Expression; Glomerular Mesangium; Glomerulonephritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Kidney; Kidney Failure, Chronic; Lovastatin; Mevalonic Acid | 1996 |
4 other study(ies) available for mevalonic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.
Topics: Animals; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Blood Proteins; Body Weight; Collagen Type I; Enzyme Inhibitors; Farnesyltranstransferase; Female; Kidney Failure, Chronic; Liver; Macrophages; Mevalonic Acid; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Prenylation; Quinolones; Random Allocation; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine; Uremia; Vascular Calcification | 2013 |
Possible role of mevalonate in the hypercholesterolemia seen in experimental chronic renal failure.
Topics: Animals; Cholesterol; Disease Models, Animal; Female; Hypercholesterolemia; Kidney Failure, Chronic; Mevalonic Acid; Mice; Mice, Inbred C57BL; Urea | 1995 |
Plasma mevalonate concentrations in uremic patients.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Creatinine; Female; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Lipids; Lipoproteins; Male; Mevalonic Acid; Middle Aged; Renal Dialysis; Uremia | 1997 |
Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failure.
Topics: Animals; Body Weight; Cholesterol; Circadian Rhythm; Creatinine; Disease Models, Animal; Hypercholesterolemia; Intestinal Mucosa; Kidney Failure, Chronic; Liver; Male; Mevalonic Acid; Rats; Rats, Wistar; Urea | 2001 |